25,000 Shares in Billiontoone, Inc. $BLLN Purchased by Seven Grand Managers LLC

Seven Grand Managers LLC acquired a new position in Billiontoone, Inc. (NASDAQ:BLLN – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 25,000 shares of the company’s stock, valued at approximately $2,046,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Nano Cap New Millennium Growth Fund L P purchased a new stake in Billiontoone in the 4th quarter worth about $82,000. Renaissance Capital LLC purchased a new stake in Billiontoone in the 4th quarter worth about $201,000. Sigma Planning Corp purchased a new stake in Billiontoone in the 4th quarter worth about $409,000. Green Alpha Advisors LLC purchased a new stake in Billiontoone in the 4th quarter worth about $436,000. Finally, FNY Investment Advisers LLC purchased a new stake in Billiontoone in the 4th quarter worth about $497,000.

Get Billiontoone alerts:

Billiontoone Stock Performance

Shares of NASDAQ:BLLN opened at $91.02 on Thursday. The stock has a market capitalization of $4.19 billion and a price-to-earnings ratio of 165.49. The stock’s 50 day moving average is $82.35. Billiontoone, Inc. has a one year low of $61.96 and a one year high of $138.70. The company has a current ratio of 10.92, a quick ratio of 10.58 and a debt-to-equity ratio of 0.18.

Billiontoone (NASDAQ:BLLN – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The company had revenue of $108.39 million for the quarter, compared to analysts’ expectations of $95.81 million. The business’s revenue was up 83.8% compared to the same quarter last year. During the same period last year, the business posted ($0.39) earnings per share. Equities research analysts predict that Billiontoone, Inc. will post 0.93 EPS for the current fiscal year.

Analysts Set New Price Targets

BLLN has been the topic of a number of recent analyst reports. BTIG Research reduced their price objective on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Guggenheim raised their target price on shares of Billiontoone from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, May 13th. JPMorgan Chase & Co. raised their target price on shares of Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Wells Fargo & Company reduced their target price on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a research report on Thursday, March 5th. Finally, Weiss Ratings raised shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday, May 15th. Six analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $125.29.

Check Out Our Latest Stock Report on BLLN

About Billiontoone

(Free Report)

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.

Further Reading

• Five stocks we like better than Billiontoone
• Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
• TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
• Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
• Keysight: The AI and Defense Stock Seeing Big Price Target Boosts

Want to see what other hedge funds are holding BLLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Billiontoone, Inc. (NASDAQ:BLLN – Free Report).

Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.